Goodpasture syndrome historical perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Krzysztof Wierzbicki M.D. [2]Ali Poyan Mehr, M.D. [3]
Overview
Overview
Goodpasture syndrome was first discovered by Dr.Ernest William Goodpasture, an American pathologist and physician. He studied the influenza pandemic in 1919 and described a fatal disease that was associated with glomerulonephritis and pulmonary hemorrhage.
Historical Perspective
Historical Perspective
- The name Goodpasture’s syndrome was first coined in 1957 by Stanton and Tange in Melbourne, Australia to describe 9 patients who presented with glomerulonephritis along with pulmonary hemorrhage.[1]
- In a book titled “Earnest William Goodpasture: Scientist, Scholar, Gentelman” published by Dr. Robert D. Collins, it was stated Dr. Goodpasture believed that the name of this syndrome should not be named after him, and deemed it inappropriate as he had not studied the disease.[2][3]
- However, the name was adopted and is used today when describing the syndrome.
References
References
- ↑ STANTON MC, TANGE JD (1958). “Goodpasture’s syndrome (pulmonary haemorrhage associated with glomerulonephritis)”. Australas Ann Med. 7 (2): 132–44. PMID 13546112.
- ↑ Collins RD (2010). “Dr Goodpasture: “I was not aware of such a connection between lung and kidney disease““. Ann Diagn Pathol. 14 (3): 194–8. doi:10.1016/j.anndiagpath.2010.02.003. PMID 20471565.
- ↑ Self S (2009). “Goodpasture’s 1919 article on the etiology of influenza-the historical road to what we now call Goodpasture Syndrome”. Am J Med Sci. 338 (2): 154. doi:10.1097/MAJ.0b013e3181acbd55. PMID 19680022.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH